Page last updated: 2024-09-04

rp 73401 and l-454,560

rp 73401 has been researched along with l-454,560 in 1 studies

Compound Research Comparison

Studies
(rp 73401)
Trials
(rp 73401)
Recent Studies (post-2010)
(rp 73401)
Studies
(l-454,560)
Trials
(l-454,560)
Recent Studies (post-2010) (l-454,560)
920231001

Protein Interaction Comparison

ProteinTaxonomyrp 73401 (IC50)l-454,560 (IC50)
Cytochrome P450 2C9 Homo sapiens (human)0.4
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.0011
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0008
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.0037
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, TD; Bland, ND; Campbell, RK; Cotter, K; Fang, AP; Gangurde, R; Garceau, N; Gechijian, L; Gustafson, AE; McAllister, G; Ochiana, SO; Ondrechen, MJ; Ortenberg, R; Pollastri, MP; Tallman, C; Wang, C; Wang, Z1

Other Studies

1 other study(ies) available for rp 73401 and l-454,560

ArticleYear
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
    Journal of medicinal chemistry, 2011, Dec-08, Volume: 54, Issue:23

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecular Structure; Pyridines; Recombinant Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

2011